Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2013; 19(32): 5286-5294
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5286
Table 3 Comparison of the somatic phenotype and genotype as a function of the patient’s clinical characteristics
MSI (n = 10)KRAS mutations (n = 16)TP53 mutations (n = 28)TP53 overexpression (n = 21)MUC5AC overexpression (n = 15)
Mean age at diagnosis (range), yr45 (18-72)51.5 (18-85)48.5 (18-79)49.5 (24-75)50 (24-76)
Sex
Males80.00%75.00%57.10%52.40%66.70%
Females20.00%25.00%42.90%47.60%33.30%
Tumor site1
Proximal50.00%18.80%21.40%28.60%33.30%
Distal50.00%81.30%78.60%71.40%66.70%
TNM stage2
I10.00%6.30%0.00%0.00%0.00%
II40.00%43.80%48.10%38.10%40.00%
III50.00%50.00%44.40%47.60%53.30%
IV0.00%0.00%7.40%9.50%6.70%